| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: | 424 | 306 | 27 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: | 2566 | 1667 | 320 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 2044 | 1494 | 463 |
 | Los Alamos National Laboratory Our mission is to solve national security challenges through scientific excellence. Los Alamos National Laboratory is one of the world’s most innovative multidisciplinary research institutions. We're engaged in strategic science on behalf of national security to ensure the safety and reliability of the U.S. nuclear stockpile. Our workforce specializes in a wide range of progressive science, technology and engineering across many exciting fields, including space exploration, geophysics, renewable energy, supercomputing, medicine and nanotechnology. Research, Science, R&D Engineering, Engineering, and Cyber Security Sectors: | 507 | 328 | 43 |
 | Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: | 2829 | 1802 | 369 |
 | UCB Inspired by patients. Driven by science. UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and … | 209 | 152 | 58 |
 | Dia & Co Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. The Challenge: 67% of American women wear sizes 14+—that’s 100 million women. Yet this majority is systematically underserved by the retail industry. The plus size community faces paltry options, unwelcoming environments, and a lack of representation—all adding up to a disappointing experience with style. Our Vision: Style freedom through a life well-lived The Dia & Co Solution: Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. We’re applying the … Sectors: | 1412 | 1131 | 208 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: | 667 | 457 | 220 |
 | Roche We advance science so that we all have more time with the people we love. Are you ready to join us? Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is … Sectors: | 586 | 535 | 13 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: | 483 | 380 | 42 |
 | Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: | 211 | 168 | 13 |
 | Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: | 956 | 764 | 83 |
 | Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 63,400 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: | 644 | 529 | 53 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 601 | 505 | 52 |
 | NHS England We lead and support the NHS in England to deliver improved care for patients. We work with NHS Improvement to act as a single organisation to better support the NHS to deliver improved care for patients: https://www.england.nhs.uk/comment-policy NHS England is increasing transparency in the NHS and improving services for patients. We work with NHS staff, patients, stakeholders and the public to improve the health outcomes for people in England. We are responsible for the stewardship of £99 billion of public funds to provide comprehensive health and care services available to all, where there is clinical need and regardless of an … Sectors: | 645 | 436 | 42 |
 | Illumina Unlocking the Power of the Genome At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of … Sectors: | 122 | 100 | 6 |
 | Illumina For Startups Illumina for Startups inspires the creation, funding, and growth of genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include • Startups Grants for founders to work with Illumina sites globally to run proof-of-concept sequencing experiments and • Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, founded in 2021. https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company … Sectors: | 524 | 254 | 90 |
 | European Bioinformatics Institute | EMBL-EBI Powering big data for the life sciences Working at EMBL-EBI gives you the opportunity to focus your energy and skills on something that really matters: using technology to contribute to discoveries that benefit humankind. We empower researchers everywhere to realise the potential of ‘big data’ in biology, and build sophisticated tools for exploring life at the atomic level. Databases, Bioinformatics training, Industry, EMBL International PhD Programme, Computational biology, Software development, User experience design, Web development, Cloud technology, Data analysis, Bioinformatics, Web production, Data infrastructure, Computational research, Software, Life sciences, Open data, Open access, COVID-19 data, and Data science Sectors: | 50 | 21 | 33 |
 | EMBL The European Molecular Biology Laboratory drives visionary research and technology development in the life sciences. Founded in 1974, EMBL is Europe’s flagship laboratory for the life sciences – an intergovernmental organisation with more than 80 independent research groups covering the spectrum of molecular biology. It operates across six sites: Heidelberg, Barcelona, Hamburg, Grenoble, Rome and EMBL-EBI Hinxton. www.embl.org | www.embl.org/jobs Our mission is to perform basic research in molecular biology; to offer vital services to scientists in the member states; to train scientists, students and visitors at all levels; to develop new instruments and methods in the life sciences and … Sectors: | 100 | 71 | 17 |
 | AstraZeneca What science can do We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 2284 | 1657 | 119 |
 | Alexion Pharmaceuticals, Inc. Rare inspiration. Changing lives. Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in … Sectors: | 172 | 121 | 18 |
 | MSD We aspire to be the premier research-intensive biopharmaceutical company. At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of … Sectors: | 1250 | 1067 | 113 |
Biotechnology